GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NovAccess Global XSNX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

—

FY2015FY2024

Net income

−$4.8m

FY2015FY2024

Free cash flow

−$624,640

FY2015FY2024

Shareholders' equity

−$7.8m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue—————$1.6m$665,017$1.2m$750,556$1.2m
Research and development$154,362$154,362$186,115$146,085——————
Operating income−$2.5m−$2.5m−$1.4m−$2.7m−$828,892$207,280−$202,294−$71,840−$207,857−$222,222
Net income−$4.8m−$4.8m−$1.7m−$2.5m−$6.8m$2.3m−$4.0m−$498,663−$242,866−$1.3m
Diluted earnings per share-0.23-0.19-0.09-0.17-0.730.40-0.72-0.43-0.29-1.87

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets$62,248$62,248$124,901$208,134$178$215,192$154,181$48,294$65,902$94,867
Cash and short-term investments$21,415$21,415$64,251$180,668$178$7,964$41,090$23,056$22,172$78,770
Total liabilities$7.9m$7.9m$4.8m$4.1m$3.6m$2.5m$4.8m$1.1m$906,350$974,118
Debt$2.2m$2.2m$1.3m$307,536$242,991$221,297$241,104$261,321$293,886$227,418
Shareholders' equity−$7.8m−$7.8m−$4.7m−$3.9m−$3.6m−$2.2m−$4.6m−$1.0m−$840,448−$879,251
Shares outstanding21m25m19m14m9m6m6m1m1m1m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations−$624,636−$624,636−$903,489−$682,333−$93,190−$6,542−$123,966−$44,844−$171,972−$207,068
Capital spending−$4−$4—−$3—−$2,284−$2,284−$772−$626−$626
Free cash flow−$624,640−$624,640−$903,489−$682,336−$93,190−$8,826−$126,250−$45,616−$172,598−$207,694

Latest quarters

By quarter end

Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022
Operating income−$315,349−$315,349−$232,560−$257,550−$410,010−$484,640−$1.1m−$517,120
Net income−$936,333−$936,333−$492,594$1.3m−$1.8m−$779,639$453,764−$2.6m
Diluted earnings per share-0.04-0.04-0.020.05-0.07-0.030.02-0.14
Total assets$273,559$273,559$85,645$17,338$62,248$177,027$103,459$58,544
Cash and short-term investments$794—$9,812$1,505—$61,464$21,991$38,944
Debt$2.1m—$2.2m$2.2m—$1.9m$1.8m$1.5m
Shareholders' equity−$7.4m−$7.4m−$6.9m−$6.4m−$7.8m−$6.2m−$5.7m−$7.0m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-3.0%—19.0%
Net income23.8%—9.4%

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return1700%248%-11%2791%40%201%-8%20%-50%-17%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1000-to-1 reverse split · 26 Aug 2020
  • 20-to-1 reverse split · 7 Oct 2003

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.